Key result
In STEMI patients undergoing primary PCI, ongoing DAPT at admission was independently associated with worse clinical outcomes.
Why the study?
Does ongoing DAPT at admission or smoking status affect long-term outcomes in STEMI patients undergoing primary PCI?
Cohort (n=713)
Yes
Does ongoing DAPT at admission or smoking status affect long-term outcomes in STEMI patients undergoing primary PCI?
In STEMI patients undergoing primary PCI, ongoing DAPT at admission is an independent predictor of worse outcomes, while current smoking paradoxically predicts better outcomes.
Answers are grounded in this paper and cite their sources.
May flag higher-risk STEMI patients for closer monitoring; leaves open whether ongoing DAPT independently worsens prognosis or reflects confounding.
BACKGROUND: Several clinical and laboratory variables have an impact on the prognosis of STEMI patients undergoing PPCI; however, little is known about the role of ongoing DAPT at the time of the event and the smoking status as prognostic factors affecting the outcome of these patients. METHODS AND RESULTS: Seven-hundred and thirteen consecutive STEMI patients undergoing PPCI, admitted to the S. Anna and S. Sebastiano Hospital (Caserta, Italy) and to the OLV Clinic (Aalst, Belgium), between March 2009 and December 2011, were retrospectively enrolled. Rescue PCI was the only exclusion criterion. Primary end-point was the combination of death for all causes, re-infarction, stroke, and target lesion revascularization (TLR). Patients already on DAPT at admission (26.4%) showed a significant increase in the event rate at univariate analysis (HR 2.34, CI 1.62-3.75, P < 0.05), while current smokers (56.5%) had a lower event rate, as compared to non-smokers (HR 0.67, CI 0.46-0.96, P < 0.05). In smoking patients already on DAPT at admission, a lower event rate was observed than in non-smoking patients on DAPT. Although, patients already on DAPT had a higher-risk profile (renal impairment, ongoing statin treatment, ST resolution <50%, and Killip class >1 were more frequently present than in patients not on DAPT), Cox regression analysis confirmed that both DAPT (HR 1.74, 95%CI 1.20-2.53, P < 0.01) and smoking status (HR 0.69, 95%CI 0.48-1.00, P < 0.05) retained their statistical significance, as they and were significantly associated with a worse and a better outcome, respectively, underlying their role as independent prognostic factors. CONCLUSIONS: Not being a current smoker and ongoing DAPT at admission, in patients with STEMI undergoing PPCI, represent independent negative prognostic value.
No takes yet. Share an insight, caveat, or question.
Ciccarelli et al. (2016) conducted a cohort in ST-segment elevation myocardial infarction (STEMI) (n=713). Ongoing DAPT at admission vs. No DAPT at admission was evaluated on Combination of death for all causes, re-infarction, stroke, and target lesion revascularization (TLR) (HR 1.74, 95% CI 1.20-2.53, p=<0.01). In STEMI patients undergoing primary PCI, ongoing DAPT at admission was independently associated with worse clinical outcomes.
Synapse has enriched 10 related papers. Consider them for comparative context: